| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), ZTS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 105.1K | - | - | |
| Dir | 28.4K | - | - | |
| Dir | 27.9K | $2.11M | - | |
| CFO | 22.1K | - | - | |
| VP | 15.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2020 | Alaix Juan Ramon | Director | Sale+OE | 83,771 | $143.93 | $12,056,894.63 | -46.6% | |
| Feb 19, 2020 | Chen Heidi C.47 | Executive Vice President | Sell | 3,289 | $143.41 | $471,675.49 | -16.8% | |
| Feb 19, 2020 | Lagano Roxanne70 | Executive Vice President | Sale+OE | 4,463 | $143.41 | $640,038.83 | -11.1% | |
| Feb 19, 2020 | Trawicki Roman48 | Executive Vice President | Sale+OE | 5,499 | $143.42 | $788,666.58 | -56.3% | |
| Feb 3, 2020 | Chen Heidi C.47 | Executive Vice President | Sale+OE | 1,179 | $134.58 | $158,669.82 | -9.3% | |
| Jan 21, 2020 | Chen Heidi C.47 | Executive Vice President | Sale+OE | 15,329 | $139.81 | $2,143,114.58 | -57.2% | |
| Jan 15, 2020 | Trawicki Roman48 | Executive Vice President | Sell | 2,199 | $137.41 | $302,164.59 | -100% | |
| Dec 16, 2019 | Lewis Clinton A. Jr.46 | Executive Vice President | Sale+OE | 6,123 | $124.93 | $764,946.39 | -18.0% | |
| Dec 3, 2019 | David Glenn | Chief Financial Officer | Sale+OE | 21,301 | $120.14 | $2,559,075.17 | -63.4% | |
| Nov 27, 2019 | Knupp Catherine A. | Executive Vice President | Sale+OE | 28,563 | $121.37 | $3,466,792.05 | -36.3% |